A listing of human tumor antigens recognized by T cells

@article{Renkvist2001ALO,
  title={A listing of human tumor antigens recognized by T cells},
  author={N. Renkvist and C. Castelli and P. Robbins and G. Parmiani},
  journal={Cancer Immunology, Immunotherapy},
  year={2001},
  volume={50},
  pages={3-15}
}
Complete list of abbreviations of tumor antigens 707-AP 707 alanine proline-AFP alpha (α)-fetoprotein-ART-4 adenocarcinoma antigen recognized by T cells 4 BAGE B antigen-β-catenin/m β-catenin/mutated-Bcr-abl breakpoint cluster region-Abelson - CAMEL CTL-recognized antigen on melanoma CAP-1 carcinoembryonic antigen peptide-1-CASP-8 caspase-8 CDC27m cell-division-cycle 27 mutated-CDK4/m cycline-dependent kinase 4 mutated-CEA carcino-embryonic antigen-CT cancer/testis (antigen)-Cyp-B cyclophilin B… Expand

Topics from this paper

Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase κ as a Novel, Class II HLA-Restricted Melanoma Antigen1
TLDR
It is shown that lymphocytes purified from a tumor-infiltrated lymph node of a melanoma patient that had remained disease free for 10 years after surgical resection of a lymph node metastasis comprised oligoclonal class II HLA-restricted CD4+ T cells recognizing the autologous tumor cells in vitro. Expand
Defining MHC class II T helper epitopes for WT1 tumor antigen
TLDR
Because HTL responses to TAA are known to be important for promoting long-lasting anti-tumor CTL responses, the newly described WT1 T-helper epitopes could provide a useful tool for designing powerful vaccines against WT1-expressing tumors. Expand
Cd8 T‐cell recognition of human 5T4 oncofetal antigen
TLDR
There is a repertoire of CD8 T cell recognition of 5T4 in normal human donors and some candidate HLA‐A*0201 epitopes have been identified. Expand
Identification of a Novel Human Cancer/Testis Antigen, KM-HN-1, Recognized by Cellular and Humoral Immune Responses
TLDR
Serologic screening of a cDNA expression library of human testis identified a novel cancer/testis antigen, KM-HN-1, which elicited humoral immune responses in patients with various types of cancer. Expand
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
TLDR
Since CT antigens are immunogenic and highly restricted to tumors, their discovery has led directly to the development of antigen‐specific cancer vaccines, and clinical trials with MAGE‐A and NY‐ESO‐1 are in progress. Expand
HER-2, gp100, and MAGE-1 Are Expressed in Human Glioblastoma and Recognized by Cytotoxic T Cells
TLDR
The presence of mRNA and protein expression in 43 primary glioblastoma multiforme cell lines and 7 established human GBM cell lines is characterized to indicate that HER-2, gp100, and MAGE-1 could be used as tumor antigen targets for surrogate assays for antigen-specific CTLs or to develop antigen- specific active immunotherapy strategies for glioma patients. Expand
Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8+ T Cells: Implication for Cancer Immunotherapy
TLDR
A novel HLA-A*02-restricted SATB1-derived peptide epitope is identified, which is recognized by CD8+ T cells, which, in turn, recognizes and kills HLA*02+ SATB 1+ tumor cells. Expand
ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes.
TLDR
Results show the existence of functional anti-ALK CTL precursors within the peripheral T-cell repertoire of healthy donors, clearly indicating ALK as a tumor antigen and ALK-derived peptides, p280-89 and p375-86, as suitable epitopes for the development of vaccination strategies. Expand
Recognition of Six-Transmembrane Epithelial Antigen of the Prostate–Expressing Tumor Cells by Peptide Antigen–Induced Cytotoxic T Lymphocytes
TLDR
These CTLs were able to respond to tumor cells that express HLA-A2 and STEAP (colon, bladder, prostate, Ewing's sarcoma, and melanoma) and provide strong evidence that STEAP-292 is naturally processed by many tumor types and is presented in the context of HLA -A2 in sufficient amounts to allow recognition by CTLS. Expand
Immunological profiling of a panel of human ovarian cancer cell lines
TLDR
Each of the 11 ovarian cancer lines is characterized by a unique expression pattern of epithelial/fibroblast markers, MHC molecules, tumor antigens, and immunosuppressive cytokines, which will increase the usefulness of these cell lines in identifying the antigen recognized by ovarian cancer-specific CTL. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 178 REFERENCES
The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes.
TLDR
The identification of CTLs specific for a peptide epitope encoded by DAM genes are described, for the first time, and suggest that DAM genes might encode a new group of tumor-specific antigens useful for the design of specific antitumor vaccines. Expand
Isolation of a New Melanoma Antigen, MART-2, Containing a Mutated Epitope Recognized by Autologous Tumor-Infiltrating T Lymphocytes1
Using cDNA expression cloning, a cDNA encoding a novel human melanoma Ag, MART-2 (melanoma Ag recognized by T cells-2), recognized by HLA-A1-restricted CD8+ T cells from tumor-infiltratingExpand
Identification of a Novel Major Histocompatibility Complex Class II–restricted Tumor Antigen Resulting from a Chromosomal Rearrangement Recognized by CD4+ T Cells
TLDR
This represents the first demonstration that a fusion protein resulting from a chromosomal rearrangement in tumor cells serves as an immune target recognized by CD4+ T cells. Expand
Human tumor antigens recognized by T lymphocytes
TLDR
It appears increasingly unlikely that immunization of patients against one of these antigens will cause harmful immunological side effects caused by the expression of the relevant gene in the testis, and these conclusions are further strengthened by immunization studies carried out with mouse tumor antigen P815A, which is encoded by a gene that is also expressed only in thetestis. Expand
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
TLDR
The isolation of a cDNA clone encoding beta- catenin was reported, which was shown to be recognized by the tumor-infiltrating lymphocyte (TIL) 1290, a HLA-A24 restricted melanoma-specific CTL line from patient 888, indicating that this represented a unique mutation in this patient's melanoma. Expand
A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes
TLDR
A gene encoding antigenic peptides of human squamous cell carcinomas (SCCs) recognized by human histocompatibility leukocyte antigens (HLA)- A2601–restricted CTLs is identified and may be useful for the specific immunotherapy of HLA-A2601+ epithelial cancer patients. Expand
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
TLDR
It is reported here the identification of the gene coding for MZ2-F, another antigen recognized by autologous CTL on Mz2-MEL cells. Expand
In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.
TLDR
These studies form a rational basis for the use of PSA peptides or recombinant vectors encoding PSA in the development of anticancer vaccine immunotherapy protocols for patients with prostate cancer. Expand
A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
TLDR
The identification of an antigen recognized by autologous cytolytic T lymphocytes on a human squamous cell carcinoma of the oral cavity is reported, encoded by a mutated form of the CASP-8 gene, suggesting that a significant fraction of the point mutations generating a tumor antigen also play a role in the tumoral transformation or progression. Expand
Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia.
TLDR
CTL with similar functional capacities were found with high frequencies and cloned from one patient's bone marrow indicating that ETV6-AML1-specific anti-ALL CTL are, at least in some patients, spontaneously stimulated and might participate to host antileukemia defense. Expand
...
1
2
3
4
5
...